Today: 21 May 2026
CleanSpark stock leaps 22% to $10.08 — what CLSK traders watch before Monday’s open
8 February 2026
2 mins read

CleanSpark stock leaps 22% to $10.08 — what CLSK traders watch before Monday’s open

New York, Feb 8, 2026, 08:54 (EST) — That’s a wrap for the session—market is closed.

  • CleanSpark jumped about 22% Friday, closing out the day at $10.08.
  • The bitcoin miner’s results, and its talk of “AI-ready” sites, had the stock moving going into the weekend.
  • On deck: what’s next for bitcoin. U.S. jobs data and inflation numbers are also expected later this week.

CleanSpark Inc shares jumped about 22% on Friday, closing out at $10.08. The Nasdaq-listed bitcoin miner had just come through a choppy two-day run.

This one’s a whopper. CleanSpark has become a proxy for bitcoin’s sharp price moves—and for the argument over whether miners can really turn cheap energy into steady data-center revenues. Shares have drawn in investors eager for either story, but those same buyers have just as swiftly pulled back.

No trades in U.S. stock markets this Sunday, which means investors will have to wait until Monday’s opening bell for fresh sentiment checks. Bitcoin, meanwhile, is showing some life—up about 3.4% and trading just shy of $71,340.

Wild price action in Bitcoin hasn’t let up. The cryptocurrency surged above $70,000 on Friday, erasing steep losses after plunging to a 16-month low earlier in the day. The rebound gave some relief to crypto-exposed stocks before the session wrapped.

CleanSpark shares saw heavy action on Friday, with trading volume spiking to about 41 million, according to market data.

CleanSpark, which primarily generates revenue from bitcoin mining but reports results in U.S. dollars, posted an 11.6% jump in quarterly revenue to $181.2 million on Feb. 5. For the quarter ended Dec. 31, net loss reached $378.7 million, or $1.35 per basic share. Adjusted EBITDA came in at negative $295.4 million, stripping out costs like interest, taxes and depreciation. The company finished the quarter with $458.1 million in cash and held bitcoin valued at roughly $1.0 billion on its books. CEO Matt Schultz called it “one of the strongest balance sheets in our sector.” CFO Gary Vecchiarelli said CleanSpark is “no longer a single-track business” as it expands further into AI and high-performance computing data centers. CleanSpark Investor Relations

CleanSpark reported mining 573 bitcoin in January, with its operational hashrate reaching 50 exahashes per second for the month. The company ended Jan. 31 holding 13,513 bitcoin. Executives also flagged a pending land-and-power agreement for a Texas data center, saying they aim to close the deal within the current quarter, pending sign-offs.

Wall Street is still wrestling with how much AI buzz belongs in the stock’s price. Brett Knoblauch at Cantor Fitzgerald held his “Overweight” rating as of Feb. 6, but cut his target to $17 from $21, according to StockAnalysis.com’s analyst log. StockAnalysis

CleanSpark shares elbow their way in alongside other U.S.-listed miners—think Marathon Digital and Riot Platforms. Movements in all three typically shadow bitcoin, and traders often jump in or out quickly depending on sentiment around crypto stocks and data center exposures.

But here’s the snag: CleanSpark’s earnings are at the whim of bitcoin’s swings, thanks to its crypto holdings distorting the figures. The core mining operation? Still exposed to the ups and downs of bitcoin prices, shifting network difficulty, and volatile energy bills—none of which are predictable. As for those big AI data-center leases, don’t expect speed. Permits and utility agreements can drag on, holding up land or power deals for months.

The sector’s bracing for key macro headlines. Wednesday, Feb. 11 has U.S. January jobs on deck, with CPI for January dropping that Friday, Feb. 13. Either release could swing rate expectations and stir up action in stocks pegged to bitcoin shifts.

Stock Market Today

  • Analysts Boost Broadcom Price Targets Despite Stock Dip
    May 20, 2026, 11:22 PM EDT. Broadcom (AVGO) shares fell 6.5% to $411.07 on May 19, retreating from a record high of $439.79 on May 14. Despite this drop, several major analysts raised their price targets. Wells Fargo lifted its target to $545 from $430, TD Cowen to $500 from $405, and UBS to $490 from $475, all maintaining buy ratings. Evercore ISI's Mark Lipacis, a top-ranked analyst, raised his target to $582, citing growing demand for Broadcom's custom AI chips amid shifts in AI workloads. Risks remain from semiconductor market volatility and geopolitical tensions impacting chip deals. Broadcom's strategic moves, including its VMware acquisition and partnerships with Google and Meta for AI-focused chips, position it well in enterprise infrastructure and AI growth.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Applied Digital stock surges 25% to $34.95 — what APLD investors are watching next week
Previous Story

Applied Digital stock surges 25% to $34.95 — what APLD investors are watching next week

Tencent stock price: WeChat AI “red packet” fight shadows Monday open after HK$547.50 close
Next Story

Tencent stock price: WeChat AI “red packet” fight shadows Monday open after HK$547.50 close

Go toTop